Small businesses are operating under ever-escalating cyber risk. They must store and protect enormous (to them) volumes of data across onsite, cloud and edge locations while ensuring seamless access, ...

The world’s largest chipmaker just flipped the AI investment narrative from “faster” to “leaner,” and the stocks that benefit most may surprise you.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NetApp remains a compelling 'Buy' as valuation discounts persist despite improving operational performance and strong AI-driven demand signals. NTAP’s billings accelerated to 10% growth in Q3, ...

It’s a good time for Elmer Rice’s “The Adding Machine,” which can only mean that it’s once again a bad time for workers. I couldn’t recall when I last saw the 1923 expressionist drama about an ...

NetApp is rated a 'Buy' at $105/share, offering a 15%+ annualized upside to a fair value of $136/share by 2028-2029E. NTAP's stable margins, proven 12%+ long-term EPS growth, and high customer ...

Data storage company NetApp Inc. delivered earnings and revenue that came in ahead of Wall Street’s forecasts and raised its guidance for the full year, citing strong demand from customers pursuing ...

Disclosure: Steve McDowell is an industry analyst who engages in, or has engaged in, research, analysis and advisory services with many technology companies, including NetApp and VAST Data. No company ...

Need to make a last-minute addition to your latest Amazon Prime order? Well, you're in luck because there's a new way to make changes on the Amazon app. The e-commerce giant has launched a new feature ...

What if you could master the majority of a powerful automation tool without spending weeks or months learning every single feature? Here’s the surprising truth: with n8n, you don’t need to know it all ...

Removing lymph nodes during cancer surgery has saved countless lives in many tumour types. Yet recent research is challenging parts of this long-standing practice. Imagine your body’s immune defences ...